Beyond Air, Inc. (NASDAQ: XAIR) shares are rocketing on Tuesday after the company disclosed a deal with XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) to sell 85% of its subsidiary company, NeuroNOS Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results